Trademark applications and grants for Chemocentryx, Inc.. Chemocentryx, Inc. has 30 trademark applications. The latest application filed is for "a symbol or image mark"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | 835 Industrial Ave. Suite 600 San Carlos, CALIFORNIA UNITED STATES 94070 |
Patent Application | Date |
---|---|
TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH CCR2 ANTAGONISTS 20220296601 - 17/805280 MIAO; Zhenhua ;   et al. | 2022-09-22 |
DOSING AND EFFECT OF C5a ANTAGONIST WITH ANCA-ASSOCIATED VASCULITIS 20220296576 - 17/519266 DENG; Jun ;   et al. | 2022-09-22 |
METHODS OF TREATING GENERALIZED PUSTULAR PSORIASIS WITH AN ANTAGONIST OF CCR6 OR CXCR2 20220280481 - 17/527939 CAMPBELL; James J. ;   et al. | 2022-09-08 |
TREATMENT OF C3 GLOMERULOPATHY USING A C5A INHIBITOR 20220257580 - 17/556188 SCHALL; Thomas J. | 2022-08-18 |
METHODS OF TREATING SOLID TUMORS WITH CCR2 ANTAGONISTS 20220241290 - 17/481829 CAMPBELL; James J. ;   et al. | 2022-08-04 |
NCAGE Code | 1KMV4 | CHEMOCENTRYX, INC. |
CAGE Code | 1KMV4 | CHEMOCENTRYX, INC. |
S.A.M. Registration | 1KMV4 [2356900] | CHEMOCENTRYX, INC. |
SEC | 0001340652 | ChemoCentryx, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.